Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03406949 |
Title | MGD009/MGA012 Combination in Relapsed/Refractory Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | MacroGenics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope Medical Center | Duarte | California | 91010 | United States | Details | |
University of Southern California | Los Angeles | California | 90033 | United States | Details | |
Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92663 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02214 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
START (South Texas Accelerated Research Therapeutics) - Midwest | Grand Rapids | Michigan | 49546 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
Mary Crowley Cancer Center | Dallas | Texas | 75251 | United States | Details | |
University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Virginia Cancer Specialists | Fairfax | Virginia | 22031 | United States | Details |